Insulin Syringes Market  Outlook, Industry Demand and Supply, and Top Manufacturers Analysis Report

Rising demand for insulin syringes, due to increase in prevalence of diabetes, is a key factor driving market revenue growth

.

The global insulin syringes sizes market size is expected to reach USD 2.69 Billion in 2030 and register a revenue CAGR of 6.9% over the forecast period, according to latest report by Reports and Data. Rising demand for insulin syringes sizes, due to increase in prevalence of diabetes, is expected to drive market revenue growth during the forecast period. Increasing expenditure on healthcare facilities and medicine is also expected to drive revenue growth of the market over the forecast period. Rising prevalence of diabetes and increasing number of patients suffering from it have considerably increased healthcare spending for treatment. In the past few years, healthcare expenditure rose to almost 3.50 trillion only in the US and is expected to rise further during the forecast period.

However, rising popularity of insulin pens is expected to hamper market revenue growth during the forecast period. Insulin pens, as compared to insulin syringes sizes, require lesser steps for insulin administration, and most of them come pre-filled with insulin. Therefore, the user just needs to adjust the dosage and inject the insulin. On the other hand, insulin syringes sizes require a better skill set, and chances of mistakes are also high. Majority of diabetes patients have found the use of insulin pens more convenient than conventional syringes.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2739

Some Key Factors Contributing to the Global Pharma Healthcare Market Growth

Unprecedented revenue growth of the global pharma healthcare industry is attributed to factors such as rising prevalence of chronic and acute diseases worldwide, increasing geriatric population, rising awareness of health wellness among consumers, and growing demand for more advanced healthcare services. Increasing demand for advanced drugs and therapeutics, growing availability of next-generation diagnostics and treatment options – especially in developing countries like India and China – rise in RD activities and clinical trials in the pharmaceutical and biotechnology sectors, increasing public and private investments in healthcare research projects, and rising consumer expenditure on healthcare are among the other significant factors contributing to the industry revenue growth.

Some Key Highlights in the Report

  • The 3/10 cc syringe (0.3 ml) segment is expected to account for largest revenue share over the forecast period. These syringes can hold up to 30 units of insulin and are calibrated in units to avoid any dosage error. Rising prevalence of diabetes and obesity globally, and increasing use of 0.3 ml syringes by patients for injecting insulin are expected to drive revenue growth of this segment during the forecast period.
  • Type-2 diabetes segment is expected to account for largest revenue share in the global insulin syringes sizes market between 2022 and 2030. A major percentage of diabetes patients suffers from type-2 diabetes, which was earlier common only among adults, but nowadays, younger children are also being diagnosed with type-2 diabetes. Type-2 diabetes, in most cases, is diagnosed after a long time of onset, which necessitates immediate treatment. This is expected to drive revenue growth of the segment over the forecast period.
  • North America insulin syringes sizes market is expected to account for largest revenue share during the forecast period. The US contributed significantly to revenue growth of the North America market, as there is rapid increase in obesity and adoption of unhealthy lifestyles in the country. Supportive government initiatives to prevent and reduce diabetes and other chronic diseases in Canada and Mexico have also contributed to market revenue growth and is expected to continue to do so in the near future.
  • In January 2020, Novo Nordisk A/S announced that they got approval from Food and Drug Administration (FDA) for Fiasp, the mealtime insulin for children suffering from diabetes. This initiative was taken to treat and prevent diabetes in younger population.

Top Players in the Global insulin syringes sizes Market:

Nipro Medical Corporation, Biocon Ltd., Terumo Corporation, Cardinal Health Inc., Novo Nordisk A/S, Abbott Laboratories, Becton, Dickinson and Company, Hindustan Syringes and Medical Devices Ltd., Teleflex, and Braun Melsungen.

The coronavirus pandemic has had a drastic impact on the global healthcare industry, with rising cases of COVID-19 worldwide, substantially growing hospital admission and readmission rates, and rising demand for telehealth and telemedicine services for remote patient monitoring. Furthermore, rising focus on development of rapid COVID-19 diagnostics such as the RT-PCR test kits, increased government funding for vaccine development, stringent regulatory norms and protocols for COVID-19 safety, and increasing sales of COVID-19 safety equipment, such as N-95 masks, face shields, PPE kits, and hand sanitizers, have driven the global pharma healthcare industry revenue growth over the recent past.

To know more about the report @ https://www.reportsanddata.com/report-detail/insulin-syringes-market

insulin syringes sizes Market Segmentation:

Size Outlook (Revenue, USD Billion; 2019-2030)

  • 3/10 cc syringe (0.3ml)
  • ½ cc syringe (0.5ml)
  • 1 cc syringe (1ml)

Disease Outlook (Revenue, USD Billion; 2019-2030)

  • Type-1 Diabetes
  • Type-2 Diabetes

End-use Outlook (Revenue, USD Billion; 2019-2030)

  • Hospitals Clinics
  • Homecare
  • Nursing Homes
  • Others

Global insulin syringes sizes Market Report: Regional Segmentation

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East Africa

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/2739

Read More Reports:

Regenerative Medicine Market @ https://www.biospace.com/article/regenerative-medicine-market-growth-by-2027-increased-incidence-of-genetic-disorders-and-chronic-diseases-is-projected-to-drive-demand-for-regenerative-medicine/

Tuberculosis Testing Market @ https://www.biospace.com/article/tuberculosis-testing-market-demand-2022-2028-rising-prevalence-of-tuberculosis-increasing-demand-for-technologically-advanced/

Whole Exome Sequencing Market @ https://www.biospace.com/article/whole-exome-sequencing-market-growth-by-2027-growing-clinical-diagnostics-application-of-whole-exome-sequencing-for-identifying-the-underlying-genetic-cause-of-several-diseases/

Laparoscopy and Endoscopy Devices Market @ https://www.biospace.com/article/laparoscopy-and-endoscopy-devices-market-trend-rapid-advancements-in-laparoscopy-and-endoscopy-techniques-and-devices/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problem provide our clients with the ability to secure an edge over their respective competitors.